The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen, A R J V
The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. [electronic resource] - The British journal of dermatology 08 2019 - 314-323 p. digital
Publication Type: Journal Article
1365-2133
10.1111/bjd.17641 doi
Adult
Anti-Inflammatory Agents--pharmacology
Antigens, CD20--immunology
Antimicrobial Cationic Peptides--antagonists & inhibitors
Biological Products--pharmacology
Biopsy
Female
Healthy Volunteers
Hidradenitis Suppurativa--drug therapy
Humans
Interleukin-12 Subunit p40--antagonists & inhibitors
Interleukin-17--antagonists & inhibitors
Male
Middle Aged
Organ Culture Techniques
Prednisolone--pharmacology
Skin--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors
The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. [electronic resource] - The British journal of dermatology 08 2019 - 314-323 p. digital
Publication Type: Journal Article
1365-2133
10.1111/bjd.17641 doi
Adult
Anti-Inflammatory Agents--pharmacology
Antigens, CD20--immunology
Antimicrobial Cationic Peptides--antagonists & inhibitors
Biological Products--pharmacology
Biopsy
Female
Healthy Volunteers
Hidradenitis Suppurativa--drug therapy
Humans
Interleukin-12 Subunit p40--antagonists & inhibitors
Interleukin-17--antagonists & inhibitors
Male
Middle Aged
Organ Culture Techniques
Prednisolone--pharmacology
Skin--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors